Advertisement

Topics

BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

05:45 EST 15 Feb 2018 | PMLIVE

Nektar’s NKTR-214 to be paired with Opdivo and Yervoy in a host of tumour types

Original Article: BMS pens massive $3.6bn deal for Nektar cancer immunotherapy

NEXT ARTICLE

More From BioPortfolio on "BMS pens massive $3.6bn deal for Nektar cancer immunotherapy"

Advertisement
Quick Search
Advertisement
Advertisement